How Recordati Improved Yield By 1.5% In Just Three Months

Confronted with an unexpected yield drop exceeding 4% and heightened variability at one of their single-drug manufacturing facilities, Recordati embarked on a mission to identify the underlying causes of these fluctuations. Although the pharmaceutical group consistently adhered to regulatory standards, they encountered two significant hurdles: fragmented data dispersed across various silos and insufficient resources for performing comprehensive analytics.

In their quest to overcome these challenges, Recordati forged a strategic partnership with Aizon. This collaboration aimed to harness AI-driven insights and sophisticated data integration capabilities. By leveraging Aizon's advanced technology, Recordati sought to unify their disparate data sources to enable a more holistic view of their operations. This integration was crucial for pinpointing inefficiencies and variability drivers, ultimately enhancing their manufacturing processes and ensuring more consistent yields.

Discover how this innovative approach paved the way for more reliable and efficient pharmaceutical manufacturing.